PEA Supplement (Palmitoylethanolamide): Benefits, Dosage And Safety

A PEA supplement contains palmitoylethanolamide, a fatty acid amide your body makes on its own and that also occurs naturally in many plant and animal foods. PEA is an “endocannabinoid-like” lipid: it is related to the body’s cannabinoid signaling system but acts mainly through a receptor called PPAR-alpha, calming inflammatory cells such as mast cells and microglia. Several meta-analyses of randomized trials suggest PEA reduces chronic pain, and small trials have tested it for sleep and as an add-on for mood disorders. It is sold as a dietary supplement in the US and is among the best-tolerated supplements studied.

Disclosure: nootropic.org/ may earn a commission from qualifying purchases made through links on this page, including as an Amazon Associate. This never affects which products we recommend. Learn more.

What Is Palmitoylethanolamide (PEA)?

Palmitoylethanolamide is an amide of palmitic acid, a common fatty acid, and ethanolamine. Cells and tissues throughout the body produce it, and it occurs naturally in many plant and animal foods. Research has focused on its neuroprotective, anti-inflammatory and pain-relieving actions in both the central and peripheral nervous system.^[1]

A naming note: In supplement stores, “PEA” can also mean phenylethylamine, a completely different stimulant-like compound sold for mood and energy. This page covers palmitoylethanolamide only. Read labels carefully, because the two have nothing in common pharmacologically.

In the US, palmitoylethanolamide is sold as a dietary supplement, so it is not FDA-approved for any condition and products are not reviewed for effectiveness before sale.

How PEA Works

PEA is often grouped with endocannabinoids such as anandamide, but unlike THC it is not intoxicating. A 2025 review describes its primary target as PPAR-alpha, a nuclear receptor that switches inflammatory genes on and off. Through this and related pathways, PEA reduces pro-inflammatory cytokine production, mast cell degranulation, microglial activation and oxidative stress, all of which feed into nerve pain and neuroinflammation.^[2]

That mechanism is why PEA is studied for nerve pain, inflammatory conditions and, more recently, brain conditions in which neuroinflammation may play a role.

PEA Supplement Benefits: What The Research Shows

Use	Best Evidence	Evidence Rating
Chronic pain (mixed types)	Several meta-analyses of randomized trials	Moderate
Diabetic nerve pain	Meta-analysis with high heterogeneity	Limited
Sleep onset	One randomized trial (n = 103)	Preliminary
Depression (add-on to an antidepressant)	One randomized trial (n = 58)	Preliminary
Mania (add-on to standard treatment)	One randomized trial	Preliminary
Exercise recovery	One randomized trial, no benefit	Not supported

Chronic Pain (Evidence: Moderate)

Pain is where PEA has the most research. Three meta-analyses point in the same direction:

• Viña 2025: 18 randomized trials with 1,196 patients. Pain was significantly lower with PEA (standardized mean difference −0.61), with differences at 4 weeks (−0.36) and 8 weeks (−0.66). Benefits appeared across nociceptive, neuropathic and nociplastic pain types.^[3]
• Lang-Illievich 2023: 11 double-blind randomized trials with 774 patients found a pooled pain reduction (SMD 1.68), with no major side effects attributed to PEA. The authors called for more study of the best dose and delivery.^[4]
• Prado 2026, diabetic neuropathic pain: PEA reduced pain scores, but heterogeneity was extremely high (I² = 96%), sample sizes were small, and many trials used combination formulas that make it hard to isolate PEA’s own effect.^[5]

How to read this: the direction of evidence is consistent, which is encouraging. But an effect size as large as 1.68 for a supplement is unusual and often reflects small, heterogeneous studies rather than a true effect of that size. The more conservative 2025 estimate (about −0.6) is a more realistic expectation: a moderate benefit for some people, usually after several weeks, not a fast-acting painkiller. A 2025 systematic review of PEA trials across patient groups reached a similar conclusion, rating pain and general well-being as the areas with the strongest evidence.^[6]

Persistent pain needs a diagnosis. PEA may be worth discussing with your doctor as an add-on, not as a replacement for evaluation or treatment.

Sleep (Evidence: Preliminary)

In a double-blind trial, 103 adults with sleep disturbance took 350 mg a day of a branded PEA (Levagen+) or a placebo for 8 weeks. PEA shortened the time it took to fall asleep and the time to feel fully awake, and improved cognition on waking. However, both groups improved their overall sleep quality and quantity scores to a similar degree, and actigraphy and sleep diaries showed no difference between groups in total sleep.^[7] That is a narrow, early result. For more on sleep-focused supplements, see our magnesium for brain and sleep guide and our apigenin page.

Mood As An Add-On Treatment (Evidence: Preliminary)

Because neuroinflammation is thought to contribute to some mood disorders, PEA has been tested alongside standard medication:

• Major depression: In a randomized trial of 58 patients, 600 mg of PEA twice daily added to the antidepressant citalopram for 6 weeks produced a larger drop in depression scores than citalopram plus placebo, and more patients responded (100% vs 74%). Side effects did not differ between groups. The sample was small, mostly male and followed for only 6 weeks.^[8]
• Acute mania: In a randomized trial, PEA 600 mg twice daily added to lithium and risperidone for 6 weeks reduced mania scores more than placebo.^[9]

Both trials studied PEA as an add-on to prescription treatment under psychiatric care. They do not show that PEA works on its own, and they do not apply to healthy people looking for a mood lift. Never stop or change psychiatric medication to try a supplement.

Is PEA A Nootropic?

PEA appears in “nootropic” discussions online, but we found no randomized trials showing it improves memory, focus or other cognitive measures in healthy adults. The waking-cognition finding in the sleep trial is the closest result, and it was a secondary measure.^[7] If cognitive performance is your main goal, see our best nootropics guide.

Exercise Recovery (Evidence: Not Supported)

A randomized trial in healthy men found PEA did not improve muscle soreness, strength recovery, jump performance or markers of muscle damage after a hard bout of exercise.^[10]

Micronized Vs Ultra-Micronized PEA

PEA is a fat-soluble molecule that does not dissolve well, which limits how much is absorbed from standard powder. Manufacturers have responded by reducing particle size:

• Standard (non-micronized) PEA: Larger particles; likely the least absorbed.
• Micronized PEA (m-PEA): Particles milled smaller to improve dissolution and absorption.
• Ultra-micronized PEA (um-PEA): Even smaller particles, aimed at further improving absorption.
• Cold-water-dispersible forms: Newer branded formulations that use other delivery technologies.

A 2017 pharmacology review covered these smaller-particle formulations and early data on their efficacy,^[1] and a 2025 systematic review found the strongest trial results came from ultra-micronized, micronized or cold-water-dispersible formulations.^[6] Head-to-head human comparisons between micronized and ultra-micronized PEA are lacking, so either is a reasonable choice. Standard PEA is the form we would skip.

PEA Dosage: Studied Doses

Purpose	Dose	Duration	Study
Chronic pain (pooled)	Various doses and formulations	Benefits seen at 4–8 weeks	Viña 2025 meta-analysis[3]
Sleep disturbance	350 mg/day (Levagen+)	8 weeks	Rao 2021[7]
Depression (add-on to citalopram)	600 mg twice daily (1,200 mg/day)	6 weeks	Ghazizadeh-Hashemi 2018[8]
Mania (add-on to lithium and risperidone)	600 mg twice daily (1,200 mg/day)	6 weeks	Abedini 2022[9]

Practical guidance:

• In the trials summarized here, doses ranged from 350 mg to 1,200 mg a day; the higher doses were split into two daily doses.
• Give it time. Pain benefits in trials emerged over 4 to 8 weeks, not hours.^[3]
• The best dose is not settled; reviewers have called for more dose-finding research.^[4]

Side Effects And Safety

Tolerability is PEA’s strongest selling point. The 2023 meta-analysis found no major side effects attributed to PEA in any included study,^[4] the diabetic neuropathy review reported only mild, self-limited adverse events,^[5] and the depression trial found no difference in side effect frequency between PEA and placebo.^[8]

Caveats: most trials lasted weeks to a few months, safety reporting in supplement trials is often thin, and there are no good data in pregnancy, breastfeeding or children. See our nootropic side effects guide for general precautions.

Drug Interactions And Who Should Avoid It

No significant drug interactions have been documented, and PEA has been given alongside antidepressants, lithium and antipsychotics in trials without notable problems.^[8][9] Even so:

• Tell your doctor if you use PEA with pain medications, psychiatric medications or immune-modulating drugs, since formal interaction studies are lacking.
• People who are pregnant or breastfeeding should avoid it until there is safety data.
• Anyone with new, severe or worsening pain should get a medical evaluation first.

How PEA Pairs With Other Supplements

• Curcumin: Another anti-inflammatory compound sometimes combined with PEA in multi-ingredient products. See our curcumin phytosome page.
• Agmatine: Also marketed for nerve discomfort, but agmatine has far less human evidence than PEA.
• Magnesium: Commonly used for sleep and muscle relaxation; see our magnesium glycinate page.
• Saffron: If mood is your interest, saffron has more randomized trials as a standalone supplement.

Where To Buy A PEA Supplement

Look for a product that names its form (micronized or ultra-micronized), lists the milligrams of PEA per capsule and publishes a certificate of analysis. Nootropics Depot sells micronized PEA as 400 mg capsules and as a powder; read our Nootropics Depot review for details on their testing. On Amazon, buy only from listings marked “Sold by Nootropics Depot.”

PEA Supplement FAQs

What Is A PEA Supplement Used For?

Mostly for chronic and nerve-related pain, where several meta-analyses of randomized trials suggest a moderate benefit.^[3] Smaller studies have explored sleep and mood.

Is Palmitoylethanolamide A Cannabinoid?

It is an endocannabinoid-like lipid that acts mainly through PPAR-alpha, and it is not intoxicating.^[2]

Is Micronized PEA Better?

Micronized and ultra-micronized forms were designed to improve absorption, and the strongest trial results come from these and other enhanced formulations.^[6]

How Long Does PEA Take To Work?

In pain trials, differences from control were seen by about 4 weeks and were larger at 8 weeks.^[3]

Does PEA Help With Sleep?

One trial found 350 mg a day shortened the time to fall asleep, but overall sleep improved similarly on placebo.^[7] Evidence is preliminary.

Is PEA The Same As Phenylethylamine?

No. Both are abbreviated “PEA,” but phenylethylamine is an unrelated stimulant-like compound. Check the full name on the label.

Is PEA Safe To Take Long Term?

Trials lasting up to a few months show very good tolerability,^[4] but long-term data are limited. Browse other options in our ingredient library.

References

1. Petrosino et al. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. British Journal of Pharmacology. 2017;174(11):1349-1365. PubMed
2. Das et al. Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain. Inflammopharmacology. 2025;33(1):121-133. PubMed
3. Viña et al. Meta-analysis of palmitoylethanolamide in pain management: addressing literature gaps and enhancing understanding. Nutrition Reviews. 2025;83(7):e1604-e1618. PubMed
4. Lang-Illievich et al. Palmitoylethanolamide in the treatment of chronic pain: a systematic review and meta-analysis of double-blind randomized controlled trials. Nutrients. 2023;15(6). PubMed
5. Prado et al. Efficacy, safety, and tolerability of palmitoylethanolamide in the management of diabetic neuropathic pain: a systematic review and meta-analysis. Journal of Diabetes and Metabolic Disorders. 2026;25(1):52. PubMed
6. Bortoletto et al. Palmitoylethanolamide supplementation for human health: a state-of-the-art systematic review of randomized controlled trials in patient populations. Brain, Behavior, and Immunity – Health. 2025;43:100927. PubMed
7. Rao et al. Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study. Sleep Science and Practice. 2021;5(1):12. PubMed
8. Ghazizadeh-Hashemi et al. Palmitoylethanolamide as adjunctive therapy in major depressive disorder: a double-blind, randomized and placebo-controlled trial. Journal of Affective Disorders. 2018;232:127-133. PubMed
9. Abedini et al. Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: a randomized, double-blind, placebo-controlled trial. Psychiatry and Clinical Neurosciences. 2022;76(10):505-511. PubMed
10. Schouten et al. Palmitoylethanolamide does not affect recovery from exercise-induced muscle damage in healthy males. Medicine and Science in Sports and Exercise. 2024;56(12):2372-2384. PubMed